Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015
Open accessThe DOI matches its Crossref record.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects individuals across the lifespan.ADHD medication use among pregnant women is increasing (1), but consensus about the safety of ADHD medication use during pregnancy is lacking.Given that nearly half of U.S. pregnancies are unintended (2), and early pregnancy is a critical period for fetal development, examining trends in ADHD medication prescriptions among reproductive-aged women is important to quantify the population at risk for potential exposure.CDC used the Truven Health MarketScan Commercial Database* for the period 2003-2015 to estimate the percentage of women aged 15-44 years with private employer-sponsored insurance who filled prescriptions for ADHD medications each year.The percentage of reproductive-aged women who filled at least one ADHD medication prescription increased 344% from 2003 (0.9% of women) to 2015 (4.0% of women).In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate.Prescribing ADHD medications to reproductive-aged women is increasingly common; additional research on ADHD medication safety during pregnancy is warranted to inform women and their health care providers about any potential risks associated with ADHD medication exposure before and during pregnancy.CDC used the Truven Health MarketScan Commercial Database to examine outpatient pharmacy prescription drug claims for ADHD medications among reproductive-aged (15-44 years) women during 2003-2015.These data represent a convenience sample of persons with private employersponsored insurance and their dependents in the United States.Demographic data are available for all persons enrolled at any point during the year, regardless of whether a claim is filed, and are linkable to submitted outpatient pharmacy claims.This analysis was restricted to women aged 15-44 years with ≥11 months of enrollment in a private health insurance plan that included prescription drug coverage during the year of interest.Outpatient pharmacy claims for ADHD medications were identified using national drug codes, irrespective of the indication for use.Data were analyzed to assess the annual percentage of reproductive-aged women who filled any ADHD * Truven Health Analytics, Atlanta, Georgia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L. (2018) · PLOS ONE · doi:10.1371/journal.pone.0206100 · Cited by 170
The female side of pharmacotherapy for ADHD—A systematic literature review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239257 · Cited by 86
Board, A. R., Guy, G., Jones, C. M., & Hoots, B. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108297 · Cited by 79
“Additionally, consistent with increasing trends in our study among women aged 20–39 and 40–59 years, a recent report found that ADHD stimulant prescriptions filled increased 344 % from 2003 to 2015 among reproductive-aged women (15–44 years) who were privately insured (Anderson et al., 2018).”
ResultAssessment of stimulant use and cardiovascular event risks among older adults
Tadrous, M., Shakeri, A., Chu, C., Watt, J., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.30795 · Cited by 49
“14 Moreover, given that the trials consisted of younger adult patients with a median (range) age of 36 (22-40) years, we anticipated a greater increase in risk associated with the prevalence of comorbidities among an older population.”
Background
Metadata
- Authors
- Anderson, K. N., Ailes, E. C., Danielson, M., Lind, J. N., Farr, S. L., Broussard, C. S., & Tinker, S. C.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2018-01-19
- Volume
- 67
- Issue
- 2
- Pages
- 66-70
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2782999578
- Cited by
- 54
- References
- 0
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015. https://app.cochat.ai/papers/10.15585/mmwr.mm6702a3
- The paper
- Anderson, K. N., Ailes, E. C., Danielson, M., Lind, J. N., Farr, S. L., Broussard, C. S., & Tinker, S. C. (2018). Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6702a3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.